Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Rain
Toggle navigation
Menu
Subscribe
Home
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Athenex Inc
(NQ:
ATNX
)
13.94
USD
+0.55 (+4.11%)
Official Closing Price
Updated: 7:47 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Athenex Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
CEO Dr. Johnson Lau Recuperating from COVID at Home
January 25, 2021
From
GlobeNewswire News Releases
Implied XBI Analyst Target Price: $202
January 19, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
First Week of March 19th Options Trading For Athenex (ATNX)
January 15, 2021
Investors in Athenex Inc (ATNX) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATNX options chain...
Tags
Stocks
From
Market News Video
CEO Dr. Johnson Lau Contracts COVID-19
January 08, 2021
From
GlobeNewswire News Releases
ATNX Makes Bullish Cross Above Critical Moving Average
January 07, 2021
In trading on Thursday, shares of Athenex Inc (ATNX) crossed above their 200 day moving average of $11.52, changing hands as high as $11.78 per share. Athenex Inc shares are currently trading up about...
Tags
Stocks
From
Market News Video
Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From
GlobeNewswire News Releases
First Week of February 2021 Options Trading For Athenex (ATNX)
December 18, 2020
Investors in Athenex Inc (ATNX) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATNX options chain...
Tags
Stocks
From
Market News Video
Analysts Predict 28% Gains Ahead For The Holdings of LABU
December 17, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis
December 15, 2020
-- Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp
From
PR Newswire
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
December 15, 2020
From
GlobeNewswire News Releases
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer
December 09, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TCDA
RARE
ASMB
From
Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ...
Tags
INCY
RCKT
IMV
From
Benzinga
Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready to Dilute Cyclophosphamide
December 02, 2020
From
GlobeNewswire News Releases
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ...
Tags
MYOV
SNY
BMY
From
Benzinga
Interesting ATNX Put And Call Options For July 2021
November 23, 2020
Investors in Athenex Inc (ATNX) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time...
Tags
Stocks
From
Market News Video
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
November 17, 2020
From
GlobeNewswire News Releases
Analysts Expect 56% Upside For XBI
November 06, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MYOK
IOVA
HOLX
From
Benzinga
Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update
November 05, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
BIIB
TBPH
CTMX
From
Benzinga
Investors Snag ATNX Even Cheaper Than Its Secondary Stock Offering
October 28, 2020
Looking back to 48 days ago, Athenex Inc (ATNX) priced a 10,000,000 share secondary stock offering at $11.00 per share. Buyers in that offering made a considerable investment into the company,...
Tags
Stocks
From
Market News Video
Benzinga's Top Upgrades, Downgrades For October 26, 2020
October 26, 2020
Upgrades Wedbush upgraded the previous rating for Huntington Bancshares Inc (NASDAQ: HBAN) from Neutral to Outperform. Huntington ...
Tags
CCI
CHKP
Upgrades
From
Benzinga
Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020
October 22, 2020
From
GlobeNewswire News Releases
Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan
October 12, 2020
From
GlobeNewswire News Releases
Athenex Oncology launches Your Guide to Facing Metastatic Breast Cancer, a first-of-its-kind self-care resource for people living with metastatic breast cancer (MBC)
October 09, 2020
Guide offers evidence-based recommendations for increasing resilience, reducing stress, maintaining proper nutrition, and other tips to facilitate managing MBC
From
PR Newswire
TUSA's Underlying Holdings Could Mean 10% Gain Potential
October 06, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
ATNX Makes Notable Cross Below Critical Moving Average
September 24, 2020
In trading on Thursday, shares of Athenex Inc (ATNX) crossed below their 200 day moving average of $11.98, changing hands as low as $11.80 per share. Athenex Inc shares are currently trading off about...
Tags
Stocks
From
Market News Video
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
September 23, 2020
Athenex’s first T cell therapy product cleared to advance to the first stage of clinical development in the U.S.
From
GlobeNewswire News Releases
Athenex Gets RS Rating Upgrade
September 21, 2020
Athenex shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.